OPTImisation of cancer treatment in AGEd persons : integration of geriatric assessment and aging biomarker analysis in elderly clinical cancer trials KU Leuven
Treating older patients with (breast) cancer is a major challenge. On the one hand, older persons are more vulnerable to side effects of therapy, which may severely impact on quality of life. Thus, overtreatment should be avoided, but on the other hand, undertreatment (which is common in elderly) can lead to worse survival. There is a delicate balance between benefits of therapy and risk of (sometimes life threatening) toxicity. There is an ...